MedTrace Logo

Can Fasting Decrease the Side Effects of Chemotherapy?

NCT04027478 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2019-07-22

No results posted yet for this study

Summary

This is a prospective randomized crossover trial. Patients will be randomized to the FMD or regular diet during three rounds of chemotherapy. After the third round, patients will cross over to the opposite arm. The primary hypothesis is that there will be fewer cases of Grade 2-4 nausea when patients are in the FMD sequence. The primary objective is to assess differences in toxicities in patients undergoing chemotherapy with a combination of taxol/carboplatin when using a fasting mimicking diet when compared to normal diet before and after treatment.

Conditions

  • Chemotherapy Effect
  • Chemotherapeutic Toxicity
  • Fasting

Interventions

DIETARY_SUPPLEMENT

FMD

fasting mimicking diet

Sponsors & Collaborators

  • Sutter Health

    lead OTHER

Principal Investigators

  • Stacy D'Andre, MD · Sutter Health

  • Carol Parise, PhD · Sutter Health

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-08-01
Completion
2021-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027478 on ClinicalTrials.gov